Skip to main content
NVDA+0.06%AAPL-0.17%GOOGL+0.97%MSFT-0.03%AMZN+0.02%TSM-1.02%SPCX+1.25%META-0.15%AVGO+0.39%TSLA+0.04%SKHY-0.86%MU+0.02%BRK-B+0.86%LLY+0.83%AMD-2.03%JPM+0.47%WMT+0.71%V+2.76%XOM+0.26%ASMLa-0.07%JNJ+1.93%INTC-2.22%MA+2.50%0700.HK+3.26%ABBV+1.49%CSCO+3.05%1398.HK-0.92%CVX+0.20%COST-0.11%ORCL+4.30%AP2d-0.05%AMAT-0.50%LRCX-0.55%DELL+2.04%BAC+1.32%KO+0.32%CAT+0.54%PG+0.42%UNH+2.25%3988.HK+1.66%1816.HK+0.45%0005.HK+1.82%GE+0.84%HSBA.L0.00%PM+0.34%0857.HK0.00%0939.HK+0.83%MS+1.38%NFLX-1.77%1288.HK-1.52%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%EURSEK0.00%CADJPY0.00%GBPNZD0.00%CADCHF0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%USDZAR0.00%USDHKD0.00%GBPSGD0.00%GBPZAR0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.29%ETHUSD+15.73%USDTUSD+0.01%XRPUSD+7.53%SOLUSD+8.55%TRXUSDT-0.21%ZECUSDT+1.81%DOGEUSD+9.80%XMRUSDT+1.92%LINKUSD+11.71%XLMUSD+1.30%BCHUSDT+0.63%LTCUSD+5.41%UNIUSD+1.72%SUIUSD+4.09%HBARUSDT+0.33%TONUSD+17.89%TAOUSDT+2.47%AAVEUSD+4.06%DOTUSDT+0.95%ICPUSDT+2.60%ONDOUSDT+3.31%WLDUSDT+14.74%JUPUSDT-1.96%ARBUSDT+0.83%ATOMUSDT-6.11%STXUSDT+2.26%INJUSDT+1.72%FETUSDT+3.97%PYTHUSDT-2.02%SEIUSDT+0.41%TIAUSDT+2.46%IMXUSDT-2.16%GRTUSDT-0.48%OPUSDT+3.88%IOTAUSDT+3.91%WIFUSDT+0.14%AXSUSDT+4.45%POLUSDT-0.30%FARTCOINUSDT+2.74%EOSUSDT+9.48%DYDXUSDT+0.58%GALAUSDT+3.99%ORDIUSDT+5.45%RONINUSDT+10.14%NOTUSDT+6.90%NVDA+0.06%AAPL-0.17%GOOGL+0.97%MSFT-0.03%AMZN+0.02%TSM-1.02%SPCX+1.25%META-0.15%AVGO+0.39%TSLA+0.04%SKHY-0.86%MU+0.02%BRK-B+0.86%LLY+0.83%AMD-2.03%JPM+0.47%WMT+0.71%V+2.76%XOM+0.26%ASMLa-0.07%JNJ+1.93%INTC-2.22%MA+2.50%0700.HK+3.26%ABBV+1.49%CSCO+3.05%1398.HK-0.92%CVX+0.20%COST-0.11%ORCL+4.30%AP2d-0.05%AMAT-0.50%LRCX-0.55%DELL+2.04%BAC+1.32%KO+0.32%CAT+0.54%PG+0.42%UNH+2.25%3988.HK+1.66%1816.HK+0.45%0005.HK+1.82%GE+0.84%HSBA.L0.00%PM+0.34%0857.HK0.00%0939.HK+0.83%MS+1.38%NFLX-1.77%1288.HK-1.52%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%EURSEK0.00%CADJPY0.00%GBPNZD0.00%CADCHF0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%USDZAR0.00%USDHKD0.00%GBPSGD0.00%GBPZAR0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.29%ETHUSD+15.73%USDTUSD+0.01%XRPUSD+7.53%SOLUSD+8.55%TRXUSDT-0.21%ZECUSDT+1.81%DOGEUSD+9.80%XMRUSDT+1.92%LINKUSD+11.71%XLMUSD+1.30%BCHUSDT+0.63%LTCUSD+5.41%UNIUSD+1.72%SUIUSD+4.09%HBARUSDT+0.33%TONUSD+17.89%TAOUSDT+2.47%AAVEUSD+4.06%DOTUSDT+0.95%ICPUSDT+2.60%ONDOUSDT+3.31%WLDUSDT+14.74%JUPUSDT-1.96%ARBUSDT+0.83%ATOMUSDT-6.11%STXUSDT+2.26%INJUSDT+1.72%FETUSDT+3.97%PYTHUSDT-2.02%SEIUSDT+0.41%TIAUSDT+2.46%IMXUSDT-2.16%GRTUSDT-0.48%OPUSDT+3.88%IOTAUSDT+3.91%WIFUSDT+0.14%AXSUSDT+4.45%POLUSDT-0.30%FARTCOINUSDT+2.74%EOSUSDT+9.48%DYDXUSDT+0.58%GALAUSDT+3.99%ORDIUSDT+5.45%RONINUSDT+10.14%NOTUSDT+6.90%
IN

Insulet Corp. (PODD)

NASDAQ • Healthcare

$135.28
+$0.81 (+0.6%)
Market closed

Last close at October 9, 2026 at 20:00 UTC

Open$134.19
Day Range$133.72 - $137.17
Avg. Volume (3M)1.6M
Market Cap$9.3B
P/E Ratio25.2
52 Week Range
$126.4$354.88
Next EarningsIn 25 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$801.7M100%
Gross Profitminus cost of goods$562.6M70%
Operating Incomeminus R&D and overhead$129.7M16%
Net Incomeminus taxes and the rest$95M12%

In plain terms: out of every $100 in revenue, Insulet Corp. keeps $12 as net profit.

Fundamentals & Financials

Revenue (TTM)
$3B
Net Income (TTM)
$375.3M
EPS (TTM)
$5.36
ROA (TTM)
11.86%
Current Ratio
2.48

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+5.4%Q1 2026$1.55
+19.3%Q2 2026$1.42
+12.9%Q3 2026$1.66
Next

Nov 4

in 25 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +12.9%

Insulet beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported August 5, 2026, as revenue of $801.7 million topped the $787.4 million estimate (+1.8%) and adjusted EPS of $1.66 topped the $1.47 estimate (+12.9%). Revenue rose ~24% to about $801.7 million (up from about $649.1 million a year ago), reflecting continued demand across the Omnipod platform, while profitability stayed elevated with gross margin near 70% and operating margin around 16%. Gross profit was roughly $562.6 million and operating income came in at about $129.7 million, with net income of about $95.0 million up ~322% from roughly $22.5 million a year ago. The company generated operating cash flow of about $88.4 million during the quarter. For the next period, consensus calls for EPS of $1.59 on revenue of $833.9 million.

Next report — what to expect

Insulet Corp. (PODD) reports earnings on November 4, 2026. Wall Street is looking for EPS of $1.59 on revenue of $833.1 million. For trailing context, revenue grew +23.5% year over year last quarter. Insulet has beaten EPS in 8 of 8 most recent quarters.

View full earnings history

About Insulet Corp.

Insulet Corp. designs and sells tubeless insulin-delivery devices and related medical technology, trading on NASDAQ as PODD in the healthcare sector. Its business centers on the Omnipod platform products and other wearable drug-delivery pods, and it generated $2.7 billion of revenue in FY2025.

Name
Insulet Corp.
CEO
Ashley McEvoy
Industry
Healthcare
Year Founded
2000
Employees
5,400

Today's Snapshot

AI-generated

PODD closed 0.6% above yesterday's close, in line with a firmer sector. Volume was about half of its usual level.

Trading Volume

Below 10d avg (1.8M)

864.4K

vs S&P 500 Today

Inline with Market

+0.01%

Updated: October 9, 2026 at 20:25 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
PODD exhibits relative weakness versus longer-term averages: the stock trades above short-term moving averages but remains below medium and long-term bands, a pattern that favors sellers. Momentum readings are muted to negative, with MACD slightly below neutral and RSI in the middle of its range, while ADX near 20 indicates a lack of strong trend conviction. ATR is modest, so volatility is contained, and the pivot sits just under the market as a nearby reference. Although OBV shows recent buying, price structure and moving-average alignment keep the technical stance negative. Technical takeaway: Sell — medium- to long-term averages and momentum favor downside.
All signals
  • EMA (5 indicators)$134.59 - $196.98
    Sell
  • RSI (14)44.71
    Neutral
  • Stochastic %K (14, 3, 3)47.57
    Neutral
  • MACD Level (12, 26)-2.57
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.